AN
ANSLF.US Ansell Limited
- Market cap
- USD 3.38B
- P/E
- 16.6x
- P/B
- 1.53x
- ROE
- 10.7%
- Dividend yield
- 2.38%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ANSLF.US undervalued?
Graham numberANSLF.US trades 6.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ansell Limited fundamental analysis
No fundamental analysis for Ansell Limited yet.
Ansell Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ansell Limited
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well …
Full company profileAnsell Limited financial statements
Ansell Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.37B | 1.49B | 1.50B | 1.61B | 2.03B | 1.85B | 1.63B | 1.62B | 2.00B | 2.18B |
| Gross Profit | 541M | 583M | 584M | 633M | 810M | 625M | 617M | 625M | 825M | 905M |
| Operating Income | 162M | 166M | 191M | 221M | 402M | 237M | 197M | 199M | 109M | 343M |
| EBITDA | 227M | 227M | 199M | 278M | 402M | 289M | 275M | 272M | 261M | 343M |
| Net Income | 148M | 484M | 112M | 161M | 247M | 159M | 148M | 76.5M | 102M | 213M |
| EPS | 0.99 | 3.32 | 0.81 | 1.22 | 1.90 | 1.24 | 1.17 | 0.59 | 0.70 | 1.48 |
| Balance Sheet | ||||||||||
| Total Assets | 2.45B | 2.51B | 2.37B | 2.45B | 2.74B | 2.51B | 2.52B | 3.24B | 3.32B | 3.39B |
| Total Liabilities | 1.22B | 969M | 963M | 1.05B | 1.17B | 949M | 913M | 1.33B | 1.34B | 1.37B |
| Shareholders' Equity | 1.21B | 1.53B | 1.39B | 1.39B | 1.55B | 1.54B | 1.60B | 1.89B | 1.96B | 1.99B |
| Cash & Short-term Investments | 321M | 593M | 396M | 409M | 240M | 206M | 159M | 912M | 238M | 249M |
| Total Debt | 719M | 550M | 543M | 578M | 516M | 486M | 493M | 857M | 806M | 151M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 198M | 154M | 189M | 291M | 173M | 222M | 181M | 272M | 239M | 355M |
| Capital Expenditure | 51.8M | 43.4M | 42.6M | 64.8M | 82.7M | 72.6M | 67.3M | 62.8M | 69.3M | 50.0M |
| Free Cash Flow | 146M | 88.6M | 130M | 226M | 90.1M | 149M | 113M | 214M | 170M | 305M |
| Ratios | ||||||||||
| ROE | 12.2% | 31.7% | 8.0% | 11.5% | 15.9% | 10.3% | 9.3% | 4.0% | 5.2% | 10.7% |
| ROA | 6.0% | 19.3% | 4.7% | 6.6% | 9.0% | 6.3% | 5.9% | 2.4% | 3.1% | 6.3% |
| Net Profit Margin | 10.7% | 32.5% | 7.5% | 10.0% | 12.2% | 8.6% | 9.1% | 4.7% | 5.1% | 9.7% |
| Debt to Equity | 0.60x | 0.36x | 0.39x | 0.41x | 0.33x | 0.31x | 0.31x | 0.45x | 0.41x | 0.08x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ansell Limited dividends
- Dividend yield
- 2.38%
- Forward dividend
- 0.82 USD
- Payout ratio
- 37.8%
- Ex-dividend date
- Aug 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | USD 80.4M | 0.56 | 37.8% |
| 2025 | USD 63.7M | 0.44 | 62.7% |
| 2024 | USD 53.2M | 0.41 | 69.5% |
| 2023 | USD 62.9M | 0.49 | 42.4% |
| 2022 | USD 86.8M | 0.68 | 54.7% |
| 2021 | USD 77.3M | 0.59 | 31.3% |
| 2020 | USD 61.8M | 0.47 | 38.4% |
| 2019 | USD 60.2M | 0.44 | 53.9% |
| 2018 | USD 58.3M | 0.40 | 12.0% |
| 2017 | USD 61.3M | 0.41 | 41.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Jul 1, 2003.
Who owns Ansell Limited
- Insiders 1.39%
- Institutions 65.69%
- Public & others 32.92%
- Shares outstanding 141M
- Free float 138M
Ansell Limited company profile
- Company name
- Ansell Limited
- Ticker
- ANSLF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15,000
- Fiscal year end
- June
- Address
- 678 Victoria Street, Richmond, VIC, Australia, 3121
- Phone
- 61 1 9270 7222
- Website
- ansell.com
About Ansell Limited
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, and TouchNTuff brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Ansell Limited management
10- Ms. Nathalie Ahlstrom M.Sc., TechMD, CEO & Director · born 1974
- Mr. Erik van den EndenChief Financial Officer · born 1978
- Mr. John MarsdenChief Operations & Supply Chain Officer
- Ms. Deanna JohnstonChief Information Officer
- Mr. Michael EvansSenior Director of Investor Relations and Corporate M&A
- Mr. Philippe H. RommelChief Legal Officer
- Mr. Rob HughesChief Product & Marketing Officer
- Ms. Charlotte DollChief Human Resource Officer
- Mr. Augusto M. AccorsiChief Commercial Officer of EMEA & APAC
- Mr. Sean P. SweeneyChief Commercial Officer of Americas